HQL Operating Expenses

abrdn Life Sciences Investors Shares of Beneficial Interest · Operating Expenses

HQL logo

HQL Operating Expenses

Latest reported-$77.94M
HQL Operating Expenses ($290.00K → -$77.94M)
High-resolution chart · PNG

HQL operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

abrdn Life Sciences Investors Shares of Beneficial Interest Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
791,573
1,388,771
1,171,451
1,352,667
1,157,705
1,029,979
5,319,624
5,592,934
1,255,636
13,348,836
39,176,719
88,390,469
84,128,540
75,485,597
1,350,000
790,000
760,000
820,000
970,000
710,000
660,000
610,000
510,000
590,000
450,000
240,000
230,000
290,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.